![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sustained Virologic Response With Daclatasvir Plus Sofosbuvir ± Ribavirin (RBV) in Chronic HCV Genotype (GT) 1-Infected Patients Who Previously Failed Telaprevir (TVR) or Boceprevir (BOC)
|
|
|
Reported by Jules Levin
EASL Amsterdam April 26 2013
Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, Lok AS, Hinestrosa F, Thuluvath PJ, Schwartz H, Nelson DR, Everson GT, Eley T, Wind-Rotolo M, Huang S-P, Gao M, Hernandez D, McPhee F, Sherman D, Hindes R, Symonds W, Pasquinelli C, and Grasela DM for the AI444-040 Study Group
![EASL1.gif](../images/042713/042113-5/EASL1.gif)
![EASL2.gif](../images/042713/042113-5/EASL2.gif)
![EASL3.gif](../images/042713/042113-5/EASL3.gif)
![EASL4.gif](../images/042713/042113-5/EASL4.gif)
![EASL5.gif](../images/042713/042113-5/EASL5.gif)
![EASL6.gif](../images/042713/042113-5/EASL6.gif)
![EASL7.gif](../images/042713/042113-5/EASL7.gif)
![EASL8.gif](../images/042713/042113-5/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|